Haemonetics Receives FDA Approval to Expand VASCADE MVP XL Labeling
Haemonetics announced U.S. FDA approval to expand the labeling for the VASCADE MVP XL venous vascular closure system to include procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths. With this label expansion, the VASCADE MVP XL system is approved for larger sheaths used in market-leading technologies for pulsed field ablation and left atrial appendage closure to treat atrial fibrillation.
